Literature DB >> 23643237

Is emergency department cardioversion of recent-onset atrial fibrillation safe and effective?

Brian G Cohn1, Samuel M Keim, Donald M Yealy.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a very common dysrhythmia presenting to Emergency Departments (EDs). Controversy exists regarding the optimal clinical therapy for these patients, which typically focuses on rhythm rate-control and admission or cardioversion and discharge home. CLINICAL QUESTION: Is ED cardioversion of recent-onset atrial fibrillation safe, effective, and does it result in positive meaningful patient outcomes? EVIDENCE REVIEW: Five observation studies with nearly 1600 ED patients with atrial fibrillation treated with either rate-control or cardioversion were reviewed and results compiled.
RESULTS: Overall, ED cardioversion for recent-onset AF seems safe and effective, with success rates ranging from 85.5% to 97% in these studies. Although further research should seek to identify patients at low risk for thromboembolic complication, more rigorously assess patient satisfaction, and show cost savings, emergency physicians should feel comfortable using this approach in select patients.
CONCLUSION: ED cardioversion for recent-onset AF seems safe and effective.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23643237     DOI: 10.1016/j.jemermed.2013.01.027

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  3 in total

1.  Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.

Authors:  Antonio Bonora; Gianni Turcato; Elena Franchi; Gabriele Taioli; Alice Dilda; Germana Zerman; Antonio Maccagnani; Claudio Pistorelli; Oliviero Olivieri
Journal:  Intern Emerg Med       Date:  2016-07-06       Impact factor: 3.397

2.  Impact of an Emergency Department Observation Unit Management Algorithm for Atrial Fibrillation.

Authors:  Shawna D Bellew; Merri L Bremer; Stephen L Kopecky; Christine M Lohse; Thomas M Munger; Paul M Robelia; Peter A Smars
Journal:  J Am Heart Assoc       Date:  2016-02-08       Impact factor: 5.501

3.  Vernakalant and electrical cardioversion for AF - Safe and effective.

Authors:  Alexander Simon; Jan Niederdoeckl; Karin Janata; Alexander Oskar Spiel; Nikola Schuetz; Sebastian Schnaubelt; Harald Herkner; Filippo Cacioppo; Anton Norbert Laggner; Hans Domanovits
Journal:  Int J Cardiol Heart Vasc       Date:  2019-07-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.